If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Friday, March 22, 2019 
Market Status: OPEN
About us and Governance Investor Relations Contact
Advanced search

Market News


Ammendment - Notification buyback commencement

Release Date: 7/4/2018 6:30:10 PM

IRIS Code: 42261

Current report in compliance with Law no. 24/2017 on issuers of financial instruments and market operations and FSA Regulation no. 5/2018 on issuers of financial instruments and market operations

Date of report: 04.07.2018

Issuer: Ropharma SA

Headquarters: 55 Iuliu Maniu Street, 500091, Brasov

Sole registration number: 1962437, fiscal attribute RO

Trade Register Number: J8/2886/2007

LEI code: 2138004ATSD4SVFAZ789

Share capital: 51.126.741,3 lei

Regulated market on which the issued shares are traded: BVB, Standard

Important event to be reported

The following current report represents an amendment to the current report published on July 2nd, 2018 due to an error regarding the maximum number of shares approved for the buy-back program.

ROPHARMA SA informs the shareholders that the maximum number of shares that can be bought-back is 51.126.741 not 5.112.674.




Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved